Juan Andres Moderna, Inc. (MRNA) insider trading activity

Juan Andres is Officer of Moderna, Inc.. Currently has a direct ownership of 12,803 shares of MRNA, which is worth approximately $695,971. The most recent transaction as insider was on Nov 05, 2021, when has been sold 5,000 shares (Common Stock) at a price of $240.0 per share, resulting in proceeds of $1,200,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K

0% 3M change

0% 12M change

Total Value Held $695,971

Juan Andres Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 05 2021	SELL Open market or private sale	$1,200,000 $240.0 p/Share	5,000 Reduced 100.0%	0 Common Stock
Nov 05 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Nov 03 2021	SELL Open market or private sale	$1,750,000 $350.0 p/Share	5,000 Reduced 100.0%	0 Common Stock
Nov 03 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Nov 01 2021	SELL Open market or private sale	$1,675,000 $335.0 p/Share	5,000 Reduced 100.0%	0 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Oct 29 2021	SELL Open market or private sale	$1,722,450 $344.49 p/Share	5,000 Reduced 100.0%	0 Common Stock
Oct 29 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Oct 27 2021	SELL Open market or private sale	$1,721,250 $344.25 p/Share	5,000 Reduced 100.0%	0 Common Stock
Oct 27 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Oct 25 2021	SELL Open market or private sale	$4,910,400 $327.36 p/Share	15,000 Reduced 100.0%	0 Common Stock
Oct 25 2021	BUY Exercise of conversion of derivative security	$193,200 $12.88 p/Share	15,000 Added 50.0%	15,000 Common Stock
Oct 22 2021	SELL Open market or private sale	$1,665,000 $333.0 p/Share	5,000 Reduced 100.0%	0 Common Stock
Oct 22 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Oct 20 2021	SELL Open market or private sale	$1,669,500 $333.9 p/Share	5,000 Reduced 100.0%	0 Common Stock
Oct 20 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Oct 18 2021	SELL Open market or private sale	$1,611,300 $322.26 p/Share	5,000 Reduced 100.0%	0 Common Stock
Oct 18 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Oct 15 2021	SELL Open market or private sale	$1,706,250 $341.25 p/Share	5,000 Reduced 100.0%	0 Common Stock
Oct 15 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Oct 13 2021	SELL Open market or private sale	$1,574,500 $314.9 p/Share	5,000 Reduced 100.0%	0 Common Stock
Oct 13 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Oct 11 2021	SELL Open market or private sale	$4,500,000 $300.0 p/Share	15,000 Reduced 100.0%	0 Common Stock
Oct 11 2021	BUY Exercise of conversion of derivative security	$183,150 $12.21 p/Share	15,000 Added 50.0%	15,000 Common Stock
Oct 08 2021	SELL Open market or private sale	$1,552,200 $310.44 p/Share	5,000 Reduced 100.0%	0 Common Stock

Also insider at

AVTR

Avantor, Inc. Basic Materials

Director

EVLO

Evelo Biosciences, Inc. Healthcare

Director

Juan Andres

Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account